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Abstract
Graft failure after liver transplantation may involve mitochondrial dysfunction. We examined
whether prevention of mitochondrial injury would improve graft function. Orthotopic rat liver
transplantation was performed after 18 hours' cold storage in University of Wisconsin solution and
treatment with vehicle, minocycline, tetracycline, or N-methyl-4-isoleucine cyclosporin (NIM811)
of explants and recipients. Serum alanine aminotransferase (ALT), necrosis, and apoptosis were
assessed 6 hours after implantation. Mitochondrial polarization and cell viability were assessed by
intravital microscopy. Respiration and the mitochondrial permeability transition (MPT) were
assessed in isolated rat liver mitochondria. After transplantation with vehicle or tetracycline, ALT
increased to 5242 U/L and 4373 U/L, respectively. Minocycline and NIM811 treatment decreased
ALT to 2374 U/L and 2159 U/L, respectively (P < 0.01). Necrosis and terminal deoxynucleotidyl
transferase-mediated nick-end labeling (TUNEL) also decreased from 21.4% and 21 cells/field,
respectively, after vehicle to 10.1% and 6 cells/field after minocycline and to 8.7% and 5.2 cells/field
after NIM811 (P < 0.05). Additionally, minocycline decreased caspase-3 activity in graft
homogenates (P < 0.05). Long-term graft survival was 27% and 33%, respectively, after vehicle and
tetracycline treatment, which increased to 60% and 70% after minocycline and NIM811 (P < 0.05).
In isolated mitochondria, minocycline and NIM811 but not tetracycline blocked the MPT.
Minocycline blocked the MPT by decreasing mitochondrial Ca2+ uptake, whereas NIM811 blocks
by interaction with cyclophilin D. Intravital microscopy showed that minocycline and NIM811
preserved mitochondrial polarization and cell viability after transplantation (P < 0.05).
Conclusion—Minocycline and NIM811 attenuated graft injury after rat liver transplantation and
improved graft survival. Minocycline and/or NIM811 might be useful clinically in hepatic surgery
and transplantation.
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Although liver transplantation is an established therapy for end-stage liver disease, poor initial
graft function and graft failure still occur unpredictably. Graft dysfunction is caused and
aggravated by prolonged cold ischemic storage, which leads to sinusoidal endothelial cell
killing and Kupffer cell activation within minutes after reperfusion. Parenchymal cell death
then follows after 3 to 6 hours. These events lead to graft dysfunction and failure.1,2 After
transplantation, both necrotic and apoptotic cell death pathways have been described to coexist.
3,4
In liver and other organs, the mitochondrial permeability transition (MPT) plays an important
role in the pathogenesis of warm ischemia/reperfusion injury.3,5,6 Opening of permeability
transition pores in the mitochondrial inner membrane causes the MPT.7 Permeability transition
pores nonspecifically conduct low molecular weight solutes to cause mitochondrial
depolarization, uncoupling of oxidative phosphorylation, and large-amplitude colloid osmotic
swelling. Adenosine triphosphate (ATP) depletion after uncoupling produces necrotic cell
killing (oncosis), whereas swelling leads to outer membrane rupture and release of proapoptotic
proteins such as cytochrome c from the intermembrane space that activate apoptotic pathways.
5 Thus, onset of the MPT within hepatocytes leads both to oncotic necrosis from ATP depletion
and caspase-dependent apoptosis if ATP depletion does not occur fully.3,5 Because
hepatocellular killing typically develops as a second wave beginning 3 to 6 hours after
sinusoidal endothelial cell death and Kupffer cell activation after cold storage/reperfusion
injury, parenchymal cell death may represent a second hit that extends and aggravates initial
hepatic damage.2,8,9 In this respect, if the MPT is important to parenchymal cell death after
reoxygenation, protective strategies directed to mitochondria might be beneficial.
Minocycline is a semisynthetic tetracycline antibiotic that is protective against
neurodegenerative disease, trauma, and hypoxia–ischemia.10-18 Mechanisms by which
minocycline may exert neuroprotection include inhibition of apoptotic pathways, decreased
mitochondrial release of pro-apoptotic factors such as cytochrome c,18 and up-regulation of
antiapoptotic Bcl-2 and inhibitor of apoptosis proteins.14 Furthermore, in cardiac and renal
ischemia, minocycline inhibits caspase-1 and caspase-3 activation and suppresses cytochrome
c release.10,13 A study of cold-stored rat livers also demonstrated decreased sinusoidal
endothelial cell rounding and increased viability after minocycline pretreatment.12 In another
study, minocycline protected against Fas-dependent fulminant hepatitis and death in mice.10
We investigated whether blockade of the MPT is a mechanism of minocycline cytoprotection
and whether minocycline decreases injury and improves function and survival of transplanted
liver grafts. Furthermore, we compared the effects of minocycline with those of N-methyl-4-
isoleucine cyclosporin (NIM811), a nonimmunosuppressive derivative of cyclosporin A (CsA)
that is a specific inhibitor of the MPT.
Materials and Methods
Chemicals and Reagents
NIM811 was the gift of Novartis (Basel, Switzerland). CsA was purchased from Calbiochem
(La Jolla, CA), Fluo-5N from Molecular Probes (Eugene, OR), and minocycline, tetracycline,
rhodamine 123, propidium iodide (PI), and other reagents from Sigma-Aldrich (St. Louis, MO).
Liver Harvest and Storage
Experiments involving animals were conducted using protocols approved by the Institutional
Animal Care and Use Committee. Inbred male Lewis rats (Harlan, Indianapolis, IN) weighing
250 to 280 g were used as donors and recipients to exclude immunologic interference. Donor
and recipient rats were fasted overnight before organ harvest. For the donor operation under
ether anesthesia, the liver was freed, and the common bile duct was cannulated with 24-gauge
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polyethylene tubing and divided. Ice-cold University of Wisconsin solution (10 mL) was
infused through the portal vein. The suprahepatic inferior vena cava, subhepatic inferior cava,
portal vein, and celiac artery were divided at the level of the diaphragm, left renal vein, splenic
vein, and splenic artery, respectively. The liver was excised and placed in ice-chilled University
of Wisconsin solution, and plastic cuffs (14 G, Medex, Carlsbad, CA) were placed on the portal
vein and subhepatic inferior cava before storage at 0°C to 1°C until implantation. For treating
liver explants, either lactated Ringer's solution as vehicle, minocycline, tetracycline, or
NIM811 was added to the perfusion, storage, and rinse solutions. For recipient treatment,
compounds were injected intraperitoneally 1 hour before recipient surgery.
Liver Transplantation
Orthotopic rat liver transplantation was performed under ether anesthesia using an arterialized
two-cuff method, as described previously with slight modification.19 In the recipient rat, the
proper hepatic artery was divided at its hilar bifurcation. The stump was clamped at the
gastroduodenal artery, and the bifurcation was cut to leave a funnel-shaped opening into which
a 4-mm polyethylene splint (24 G, B. Braun Melsungen, Bethlehem, PA) was inserted.20 After
dividing the bile duct at the hilum, the suprahepatic inferior cava, portal vein, and subhepatic
inferior cava were clamped and divided, and the recipient liver was removed. The donor liver
was then washed with 10 mL Ringer's solution at room temperature. Subsequently, the
suprahepatic inferior cava was anastomosed with a 7–0 Prolene (Ethicon, Somerville, NJ)
running suture. The portal vein and subhepatic inferior cava were connected in sequence by
insertion of cuffs. Both the hepatic artery and the bile duct were anastomosed over the
intraluminal polyethylene splints. The time of implantation averaged 52 minutes, and portal
vein clamping averaged 15 minutes.
Alanine Aminotransferase
Blood samples to measure alanine aminotransferase (ALT) were collected from the inferior
vena cava 6 hours after transplantation for analysis by standard methods.
Histology
Histology was evaluated 6 hours after liver transplantation. Liver tissues were fixed by
immersion in 4% buffered paraformaldehyde and embedded in paraffin. Sections (4 μm) were
stained with hematoxylin-eosin. Ten random fields were assessed for necrosis by standard
morphologic criteria (for example, loss of architecture, vacuolization, karyolysis, increased
eosinophilia). Images were captured by an image analysis system (Olympus BH-2 Microscope;
Micropublisher 5.0 RTV, Center Valley, PA), and the area percentage of necrosis was
quantified using a computer program (BioQuant BQ Nova Prime 6.7, R&M Biometrics,
Nashville, TN).
Immunohistochemistry
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) was
performed on paraffin sections using an in situ cell death detection kit (Roche Diagnostics,
Penzberg, Germany). TUNEL-positive parenchymal and nonparenchymal cells were counted
by light microscopy in 10 random high-power fields (HPF).
Caspase-3
Liver tissue (approximately 100 mg) was homogenized (Polytron PT-MR2100, Kinematica,
Luzern, Switzerland) in 1 mL lysis buffer containing 0.1% 3-[3-Cholamidopropyl)
dimethylammonio]-1-propanesulfonate, 2 mM ethylene diamione tetra-acetic acid, 5 mM
dithiothreitol, 1 mM Pefabloc, 10 ng/mL pepstatin A, 10 ng/mL aprotinin, 20 μg /mL leupeptin,
and 10 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (4-(2-hydroxyethyl)-1-
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piperazine ethanesulfonic acid) buffer, pH 7.4. The lysate was centrifuged at 21,000 g for 30
minutes. Activity of caspase-3 in the supernatant was determined using a Caspase-3
Colorimetric Assay Kit (R&D Systems, Minneapolis, MN) according to the manufacturer's
instructions. Activity was normalized to protein concentration of each sample and expressed
as fold increase compared with sham.
Survival Study
Treatment with vehicle, minocycline, tetracycline, and NIM811 was performed in a
randomized, prospective fashion, and rats were followed 30 days after surgery. Rats dying or
requiring euthanasia for presumed surgical complications within 6 hours of transplantation
were excluded.
Plate Reader Assays of the MPT
Rat liver mitochondria were isolated in 250 mM sucrose, 2 mM K+-HEPES buffer, pH 7.4, as
previously described.21 Using a ThermoMax 96-well plate reader (Molecular Devices,
Sunnyvale, CA), mitochondrial swelling was assessed from the decrease of absorbance at 540
nm of 0.5 mg/mL rat liver mitochondria suspended in 0.2 M sucrose, 20 mM Tris, 20 mM
HEPES, 5 mM succinate, 1 mM KH2PO4, 2 μM rotenone, and 1 μg/ml oligomycin at pH 7.2,
25°C, as described.22 Mitochondrial suspensions were treated with 0 to 50 μM minocycline,
0 to 50 μM tetracycline, 5 μM NIM811, or 1 μM CsA After 2 minutes of incubation, 250 μM
CaCl2 was added to induce the MPT.
In other experiments, fluorescence of the Ca2+ indicator Fluo-5N (1 μM) was determined in a
fluorescence plate reader (BMG LABTECH GmbH, Offenburg, Germany). Mitochondrial
suspensions were treated with various compounds. After 2 minutes, aliquots of 50 μM CaCl2
were added every 5 minutes.
Oxygen Uptake
Oxygen consumption was measured with a Clark electrode (Hansatech Instruments, Norfolk,
England) in medium containing 1 mg/mL rat liver mitochondria, 5 mM disodium succinate, 1
μM rotenone, 150 mM sucrose, 5 mM MgCl2, 7.5 mM KPi buffer, 25 mM K-HEPES buffer,
pH 7.4, 23°C, as described.21 Minocycline (0-100 μM), 218 μM adenosine diphosphate (ADP),
250 μM CaCl2, 2 μM CsA, and 1 μM carbonyl cyanide m-chlorophenylhydrazone were added
as indicated.
Intravital Microscopy
At 2, 4, and 6 hours after transplantation, rats were anesthetized with pentobarbital (50 mg/kg)
and connected to a small animal ventilator via a tracheostomy and respiratory tube (14-gauge
catheter) as described in a mouse model.23 Laparotomy was performed using the previous
incision line, and a 32-gauge catheter was inserted into the distal part of the right colic vein.
Using a syringe pump, membrane potential–indicating fluorophore rhodamine 123 (10 μmol/
rat) was infused via the catheter over 10 minutes. Immediately afterward, cell death–indicating
PI (0.5 μmol/rat) was infused over 3 minutes. After prone positioning of the rat, the liver was
gently withdrawn from the abdominal cavity and placed over a glass coverslip on the stage of
a Zeiss Axiovert 100 microscope (Thornwood, NY) equipped with a spinning disk confocal
imaging system (Attofluor CARV Optical Module, BD Bioimaging Systems, San Jose, CA),
a 12-bit cooled CCD camera (Hamamatsu, Bridgewater, NJ), and a 40× 1.2 NA water-
immersion objective lens for imaging the green fluorescence of rhodamine 123 and red
fluorescence of PI. In some experiments, rhodamine 123 and PI fluorescence was excited with
820-nm light from a Chameleon Ultra Ti-Sapphire pulsed laser (Coherent Inc., Santa Clara,
CA) and imaged with a Zeiss LSM 510 NLO inverted laser scanning confocal microscope
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using a 63× 1.3 NA water-immersion objective lens. Green rhodamine 123 and red PI
fluorescence was collected through 525 ± 25 nm band pass and 700 ± 25 nm band pass filters,
respectively. During image acquisition, the respirator was turned off for approximately 5
seconds to eliminate breathing movement artifacts. In 20 fields per liver, parenchymal cells
were scored for bright punctate rhodamine 123 fluorescence representing cells with polarized
mitochondria or a dimmer diffuse cytosolic fluorescence representing cells with depolarized
mitochondria. Nonviable PI-positive cells, indicated by bright nuclear fluorescence, were also
counted in the same fashion. Image analysis was performed in a blinded fashion.
Statistical Analysis
Data are presented as means ± standard error, unless otherwise noted. Statistical analysis was
performed by Student t test, analysis of variance plus Student-Newman-Keuls test, Fisher's
exact test, or Kaplan-Meier test, as appropriate, using P < 0.05 as the criterion of significance.
Results
Decreased ALT Release and Graft Necrosis After Minocycline and NIM811
Rat livers were stored for 18 hours and transplanted. Liver explants or recipients were treated
with drug or vehicle. At 6 hours postoperatively, sham-operated rats had serum ALT averaging
105 ± 15 U/L. After transplantation, ALT after vehicle treatment increased to 5242 ± 517 U/
L, which decreased to 2374 ± 280 U/L after explant and recipient treatment with 18 μM
minocycline plus 10 mg/kg minocycline 1 hour prior to surgery (P < 0.01 versus vehicle
treatment). Identical treatment of explants and recipients with tetracycline failed to decrease
serum ALT after transplantation (Fig. 1). Treatment of explants and recipients with 5 μM and
10 mg/kg NIM811, respectively, also decreased ALT levels to 2159 ± 374 U/L (P < 0.01 versus
vehicle treatment). Although treatment of liver explants alone with 18 μM minocycline
decreased ALT levels (3825 ± 457 U/L, P = 0.05), we used the combination of explant and
recipient minocycline treatment to achieve better results for further experiments. Other doses
of minocycline treatment to liver explants alone (2-200 μM) and minocycline treatment to
recipients alone (10 mg/kg) did not show a benefit on ALT release (not shown).
Graft injury was also assessed histologically at 6 hours postoperatively. Liver histology was
normal and indistinguishable in unoperated and sham-operated rats (Fig. 2A and data not
shown). After vehicle treatment of both liver explants and transplant recipients, large areas of
necrosis were present 6 hours postoperatively with a predominately pericentral and midzonal
distribution (Fig. 2B, dashed line). Explant and recipient treatment with minocycline and
NIM811 decreased hepatic necrosis from 21.4% ± 2.5% after vehicle to 10.1% ± 1.4% after
minocycline and 8.7% ± 1.3% after NIM811 (P < 0.05, Fig. 2C-E). Thus, both minocycline
and NIM811 treatment decreased hepatic necrosis by greater than 2-fold.
Decreased Graft Apoptosis After Minocycline and NIM811
TUNEL was performed on tissue sections to assess double-stranded DNA breaks that are
characteristic of apoptosis. Differentiation of parenchymal cells and nonparenchymal cells was
made on the basis of nuclear morphology and location. TUNEL-positive parenchymal and
nonparenchymal cells were rare after sham operation, averaging less than 1 cell/HPF (Fig. 3A).
At 6 hours after transplantation with vehicle treatment, TUNEL of parenchymal cells and
nonparenchymal cells in nonnecrotic areas increased to 21.2 ± 3.5 and 9.5 ± 2.5 cells/HPF,
respectively, without apparent zonal localization (Fig. 3B). Treatment with minocycline of
both explants and recipients decreased TUNEL by approximately two-thirds to 6.1 ± 1.7 cells/
HPF in parenchymal cells and by approximately half to 5.3 ± 1.9 cells/HPF in nonparenchymal
cells (P < 0.01 and P < 0.05, respectively, Fig. 3E, F). Treatment with NIM811 of both explants
and recipients decreased TUNEL by three-fourths to 5.2 ± 2.4 cells/HPF in parenchymal cells
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(P < 0.01, Fig. 3E). A trend toward decreased TUNEL-positive nonparenchymal cells was also
observed but was not statistically significant (P > 0.1). As a percentage of all parenchymal
cells, the percentage of TUNEL was 2.7% ± 0.3% after transplantation with vehicle treatment
versus 0.9% ± 0.2% and 0.8% ± 0.3% with minocycline and NIM811 treatment, respectively
(P < 0.01). The percentage of nonparenchymal cell TUNEL could not be reliably determined
because counterstaining was too weak to identify all nonparenchymal cells confidently.
To further investigate the extent of apoptosis after minocycline treatment, caspase-3 activity
was measured in liver extracts at 6 hours after transplantation with vehicle, minocycline, or
NIM811 in comparison with sham-operated livers (Fig. 3G). After sham operation, caspase
activity was nearly undetectable. After transplantation with vehicle treatment, caspase-3
activity increased 11-fold, which decreased to 4.5-fold after minocycline (P < 0.05 compared
with vehicle, Fig. 3G) and also trended lower after NIM811 (P = 0.2).
Improved Graft Survival After Minocycline and NIM811 Treatment
Graft survival was assessed by mortality out to 30 days. After transplantation with vehicle, 8
of 11 rats died within 36 hours, and 30-day survival was 27% (Fig. 4). After minocycline
treatment, 30-day survival was 60% (P< 0.05 compared with vehicle, Fig. 4). Furthermore,
graft loss was delayed, because 3 of the 4 rats died 48 hours or more after surgery. Similarly,
NIM811 treatment led to 70% survival after 30 days (P < 0.05 compared with vehicle, Fig. 4).
After tetracycline treatment, 30-day survival was 33% with all deaths occurring within 48
hours, which was not different from vehicle treatment (Fig. 4).
Inhibition by Minocycline and NIM811 But Not Tetracycline of the Mitochondrial Permeability
Transition in Isolated Rat Liver Mitochondria
The potential for minocycline to block the MPT was investigated in isolated rat liver
mitochondria. Addition of 250 μM calcium to mitochondria induced MPT-dependent swelling,
as shown by a large decrease in absorbance at 540 nm that was blocked by 1 μM CsA, an MPT
inhibitor (Fig. 5). Minocycline also blocked calcium-induced mitochondrial swelling in a dose-
dependent fashion, with nearly complete inhibition occurring at 50 μM. By contrast,
tetracycline in the same dose range had no effect on calcium-induced mitochondrial swelling
(Fig. 5). NIM811, a non-immunosuppressive CsA analog, also blocked swelling (data not
shown, see also Fig. 6), as described previously.24
Next, we compared the effects of minocycline, tetracycline, CsA, and NIM811 on calcium
uptake and retention by isolated mitochondria using Fluo-5N as a fluorescent indicator of
extramitochondrial free calcium. In vehicle (dimethylsulfoxide)-treated mitochondria, calcium
uptake was so rapid after the first 50 μM pulse of CaCl2 that increased extramitochondrial
Ca2+ was detectable only in the first fluorescence measurement, after which Fluo-5N
fluorescence returned to baseline (Fig. 6A). This pattern was repeated after a second pulse of
CaCl2, but after a third pulse calcium was not taken up into the mitochondria. Rather, calcium
previously taken up was released, an event signifying onset of the MPT. When mitochondria
were treated with CsA or NIM811, calcium retention was greatly increased, and 400 μM
CaCl2 was required to induce calcium release and onset of the MPT. In this particular
experiment, 5 μM NIM811 was employed to match the concentration used in liver storage
versus 1 μM for CsA, but previous studies showed that NIM811 is equipotent to CsA in
blocking the MPT.24
Although minocycline, like CsA and NIM811, suppressed onset of the MPT, minocycline had
a very different effect on calcium uptake and release. In the presence of 18 μM minocycline,
mitochondrial calcium uptake after a CaCl2 pulse was inhibited an estimated 65% compared
with vehicle-treated mitochondria (Fig. 6B). With successive pulses, Fluo-5N fluorescence
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increased progressively and failed to return to baseline between pulses. After the accumulated
addition of 350 μM CaCl2, no recovery of Fluo-5N fluorescence occurred. By contrast,
tetracycline-treated mitochondria were indistinguishable from vehicle-treated mitochondria.
ADP- and Ca2+-Stimulated Respiration in Minocycline-Treated Mitochondria
Ca2+/O and ADP/O ratios were determined polarographically.21 After addition of
mitochondria, an initial burst of oxygen consumption (respiration) occurred, which was
followed by a slower constant rate of oxygen consumption (state 4). After addition of 218 μM
ADP alone or 250 μM CaCl2 in the presence of 2 μM CsA to prevent the MPT, respiration
increased immediately (state 3) because of energy-dependent ADP phosphorylation or the
electrophoretic uptake of calcium. Because ADP was exhausted by conversion to ATP or
calcium was completely taken up into mitochondria, respiration returned to the original
“idling” rate of state 4. By dividing the amount of ADP or CaCl2 added by the amount of
oxygen consumed during state 3, ADP/O and Ca2+/O ratios of 1.74 and 3.1, respectively, were
calculated (Fig. 6C). With increasing minocycline (0-50 μM), ADP-stimulated state 3
respiration and ADP/O ratios were unchanged. At still higher minocycline, ADP/O decreased
35%. This was attributable to increased state 4 respiration because state 3 respiration was not
changed. By contrast, minocycline (0-100 μM) dose-dependently decreased Ca2+-stimulated
state 3 respiration without affecting Ca2+/O ratios. Together with the Fluo-5N results, these
findings indicate that minocycline (0-50 μM) has negligible effects on the rate and efficiency
of oxidative phosphorylation. Rather, minocycline inhibits calcium uptake without altering the
energetic efficiency of calcium accumulation.
Mitochondrial Dysfunction In Vivo After Liver Transplantation: Protection by Minocycline
and NIM811
At 4 hours after sham operation, intravital multiphoton microscopy showed bright fluorescence
of rhodamine 123 in hepatocytes whose punctuate pattern denoted polarization of individual
mitochondria (Fig. 7A). Cytosolic and nuclear areas had little fluorescence. PI labeling of
nuclei after sham operation was very rare, indicating the absence of cell death. By contrast, at
4 hours after liver transplantation with vehicle treatment, rhodamine 123 staining became
diffuse and dim in many hepatocytes (Fig. 7B, white arrows). Additionally, many PI-positive
red-fluorescing nuclei were observed after transplantation with vehicle treatment (Fig. 7B,
yellow arrows). PI labeling occurred both in the round nuclei of parenchymal cells and the
flattened irregular nuclei of nonparenchymal cells. Overlays of the green and red channels
showed that all PI-labeled cells also had diffuse or absent rhodamine 123 staining (Fig. 7B,
yellow arrows). Thus, all nonviable cells had depolarized mitochondria. However, some
parenchymal cells exhibited diffuse and dim rhodamine 123 staining but did not label with PI,
indicating mitochondrial depolarization before onset of cell death (Fig. 7B, white arrows).
In order to assess the time course of mitochondrial dysfunction and cell death in vivo after
reperfusion, intravital microscopy was performed at different times after transplantation. For
these experiments we used intravital spinning disk confocal microscopy of rhodamine 123 and
PI at 0 hours (sham), 2 hours, 4 hours, and 6 hours after liver transplantation. Quantification
was performed for each liver, and hepatocytes were scored for PI and rhodamine 123 staining
(Fig. 7E). In sham-operated livers, virtually no hepatocytes contained depolarized
mitochondria, and none were nonviable by PI labeling. At 2 hours after transplantation, 10.4%
± 3.2% of hepatocytes contained depolarized mitochondria but were still viable (excluded PI),
whereas 1.9% ± 0.6% of hepatocytes were both depolarized and nonviable (PI positive) (Fig.
7E). At 4 hours, 12.8% ± 0.6% of hepatocytes contained depolarized mitochondria but were
viable, and another 10.1% ± 2.3% were nonviable (and depolarized). At 6 hours, viable cells
with depolarized mitochondria were rare (2.4% ± 1.3%), and another 21.4% ± 2.5% were
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nonviable (Fig. 7E). These results illustrate a progression of mitochondrial depolarization
followed by cell death.
After transplantation with minocycline treatment, fewer hepatocytes were seen with
depolarized mitochondria (Fig. 7C). Most hepatocytes demonstrated bright, punctate staining
by rhodamine 123, indicative of their content of polarized mitochondria. PI labeling in both
hepatocytes and nonparenchymal cells also decreased after minocycline treatment. Overlays
again showed that all nonviable PI-labeled cells had diffuse or absent rhodamine 123 staining,
signifying mitochondrial depolarization, but not all cells with depolarized mitochondria were
labeled with PI. NIM811 treatment also decreased mitochondrial depolarization and loss of
viability of parenchymal and nonparenchymal cells to a similar extent as minocycline treatment
(Fig. 7D). By contrast, mitochondrial depolarization and loss of cell viability after tetracycline
treatment were indistinguishable from vehicle-treated liver grafts (data not shown).
At 4 hours after transplantation, cells were scored and counted for PI and rhodamine 123
staining for each liver (Fig. 7F). PI-labeled nonviable cells were identified as parenchymal or
nonparenchymal cells on the basis of nuclear morphology and location adjacent to sinusoids.
In sham-operated livers, 0.05 ± 0.002 hepatocytes/HPF contained depolarized mitochondria,
but no parenchymal or nonparenchymal cells were nonviable by the criterion of PI labeling.
After transplantation with vehicle treatment, 4.3 ± 0.3 hepatocytes/HPF contained depolarized
mitochondria but were still viable, whereas nonviable hepatocytes and nonparenchymal cells
were 3.3 ± 0.8 and 2.4 ± 0.4 cells/HPF, respectively (Fig. 7F). After transplantation with
minocycline treatment, viable hepatocytes with depolarized mitochondria decreased to 0.6 ±
0.3 hepatocytes/HPF (P< 0.05 versus vehicle, Fig. 7F), and nonviable parenchymal and
nonparenchymal cells decreased to 0.4 ± 0.2 and 1.1 ± 0.3 cells/HPF, respectively (P< 0.05
versus vehicle, Fig. 7F). After transplantation with NIM811 treatment, viable hepatocytes with
depolarized mitochondria also decreased to 0.7 ± 0.3 cells/HPF (P< 0.05 versus vehicle, Fig.
7F), and nonviable parenchymal and nonparenchymal cells decreased to 0.4 ± 0.4 and 0.8 ±
0.6 cells/HPF, respectively (P< 0.05 versus vehicle, Fig. 7F). Thus, minocycline and NIM811
conferred similar protection.
Discussion
Damage to liver caused by ischemia/reperfusion can be a limiting factor in clinical settings of
liver surgery and transplantation. The aim of this study was to evaluate the hypothesis that
mitochondrial dysfunction is a key event in liver graft injury. Specifically, we tested the
hypothesis that minocycline, a tetracycline previously shown to have cytoprotective properties,
decreases storage/reperfusion injury after rat liver transplantation by inhibition of the MPT.
Additionally, we investigated the effects of NIM811, a nonimmunosuppressive CsA derivative
that blocks the MPT. Our findings showed that minocycline and NIM811 decreased necrosis
and apoptosis in liver grafts after rat liver transplantation and improved graft survival to a
similar extent. Protection by both minocycline and NIM811 appeared to be attributable to
blockade of the MPT and prevention of mitochondrial depolarization, a consequence of the
MPT.
In addition to antimicrobial actions of minocycline, previous studies demonstrated its
cytoprotective potential in a variety of settings, including ischemic cardiac, renal, and central
nervous system disease.10-18 Relevant to our study, improved sinusoidal cell lining viability
during cold storage of rat liver grafts was reported previously after minocycline pretreatment,
an effect attributed to suppression of angiogenic factor production by Kupffer cells that may
cause sinusoidal endothelial cell sloughing and detachment during preservation.12 However,
the effect of minocycline on graft function and survival after transplantation has not previously
been determined. Here, our results demonstrated a more than 2-fold increase in 30-day graft
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survival after liver transplantation with perioperative minocycline treatment (Fig. 4). Similarly,
a recent study showed that minocycline protects against cell death and improves survival in a
mouse model of Fas ligation-mediated fulminant liver failure.10 Importantly, minocycline
administered up to 30 minutes after anti-Fas antibody treatment delays mortality kinetics and
rescues mice from death. After Fas ligation, cell death is predominantly apoptotic through a
mitochondrial pathway.25 Thus, protection implies that minocycline suppresses death
receptor–mediated and mitochondria-dependent apoptotic signaling, which previous studies
show to involve the MPT.26,27
In our model, minocycline decreased both necrosis and apoptosis. Necrosis assessed by ALT
and histology decreased by half at 6 hours after transplantation with minocycline treatment
(Figs. 1, 2). In hepatocytes and nonparenchymal cells, apoptosis assessed by TUNEL decreased
71% and 45%, respectively, whereas caspase-3 activity in whole liver extracts decreased 69%
(Fig. 3). NIM811 afforded similar protection with regard to parenchymal TUNEL-positive
cells (Fig. 3E), but only nonsignificant trends toward protection were seen with regard to
nonparenchymal cells (Fig. 3F, G). Necrosis represented the predominant mode of cell death
in our studies, because after liver transplantation with vehicle treatment, necrosis involved 21%
of the parenchyma, whereas TUNEL occurred in only 2.7% of hepatocytes. These findings
support earlier assessments that apoptosis contributes much less to graft storage/reperfusion
injury than necrosis.3,28 However, both modes of cell death can occur through a mitochondrial
pathway involving the MPT, a phenomenon of necrapoptosis.5. Because minocycline and
NIM811 protected against both necrosis and apoptosis, graft injury and cell death after storage/
reperfusion would appear to be largely a necrapoptotic phenomenon.
Minocycline and NIM811 protected against cell death to both nonparenchymal and
parenchymal cells after liver transplantation. In agreement with earlier studies,2,9,29 intravital
microscopy and histology suggested that endothelial cell killing occurring at early time points
after reperfusion led to parenchymal cell damage at later time points (data not shown). Indeed,
later injury to hepatocytes was more strongly protected than the earlier injury to sinusoidal
cells (Fig. 7F).
Although NIM811 is a well-established inhibitor of the MPT, the mechanism of minocycline
inhibition has been unclear. Our findings here indicate that minocycline cytoprotection like
that of NIM811 was mediated by suppression of the MPT. The MPT causes mitochondrial
depolarization with consequent uncoupling of oxidative phosphorylation, mitochondrial
swelling, and cell death by necrosis and apoptosis. Intravital confocal imaging showed directly
mitochondria depolarization after liver transplantation after a time of cold ischemic storage
leading to graft injury and failure (Fig. 7). This depolarization signifying the MPT preceded
onset of necrotic cell death. Minocycline like NIM811 substantially prevented mitochondrial
depolarization, and in isolated liver mitochondria minocycline blocked onset of CsA-sensitive
mitochondrial swelling induced by Ca2+ (Fig. 5). Tetracycline, which did not decrease graft
failure and ALT release after transplantation, did not block MPT onset in isolated mitochondria
and did not prevent mitochondrial depolarization assessed by intravital confocal microscopy
after liver transplantation. Hence, protection by minocycline seems most likely attributable to
inhibition of the MPT.
Although NIM811 and minocycline both blocked the MPT, the mechanism of blockade by the
2 agents was different. NIM811 has been shown previously to block the MPT through its
interaction with cyclophilin D.30 By contrast, we show here that minocycline blocked the MPT
by inhibiting mitochondrial calcium uptake as monitored by the calcium indicator Fluo-5N
(Fig. 6). Calcium uptake into the mitochondrial matrix space is a necessary step for the Ca2+-
induced MPT, and calcium uptake inhibitors such as ruthenium red potently block the MPT.
31,32 Simultaneous treatment with minocycline and NIM811 did not confer additional
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protection against the MPT in isolated mitochondria beyond either agent alone (data not
shown). Respiratory measurements in mitochondria showed that inhibition of mitochondrial
Ca2+ uptake by minocycline was not attributable to respiratory inhibition or uncoupling,
because ADP-stimulated state 3 respiration and ADP/O and Ca2+/O ratios were not changed
with as much as 50 μM minocycline (Fig. 6C). Rather, minocycline specifically inhibited
Ca2+-stimulated state 3 respiration consistent with inhibition of calcium uptake. Recently, high
doses (75-150 μM) of minocycline were reported to stimulate state 4 respiration and inhibit
ADP-stimulated state 3 respiration in rat brain mitochondria.32 These findings are consistent
with our observation of a decreased ADP/O ratio at 100 μM minocycline (Fig. 6C) and with
another report of complex II/III activity inhibition at the same dose.18,31
In rat liver transplantation, we observed best protection when both explants and recipient
animals were treated with minocycline (Figs. 1-4 and data not shown). Preliminary experiments
indicated that explant treatment with 18 μM minocycline yielded the greatest protection and
that no protection was observed at higher concentrations of minocycline (data not shown).
These observations are somewhat in contrast with our measurements in isolated rat liver
mitochondria in which 18 μM minocycline partially blocked the MPT, whereas 50 μM
protected nearly completely (Fig. 5). Still higher concentrations of minocycline caused partial
uncoupling and respiratory inhibition in isolated mitochondria (Fig. 6C). Minocycline is a
semisynthetic tetracycline analog with enhanced lipophilicity and tissue penetration.33 Such
properties may promote tissue uptake and serve to concentrate minocycline intracellularly,
which might explain the increased efficacy of minocycline in vivo compared with isolated
mitochondria in vitro.
Although previous studies implicated the MPT in warm ischemia/reperfusion injury,
involvement of the MPT in graft dysfunction and failure after cold organ preservation has not
been previously shown. After warm ischemia/reperfusion, specific MPT blockers, such as CsA,
NIM811, and sanglifehrin A, protect against injury.24,31,34-38 In various models, CsA
protects against both apoptosis and necrosis.36 However, the toxic and immunosuppressive
effects of CsA limit its usefulness in a clinical setting of ischemia/reperfusion. Even in a
transplantation setting, CsA is being supplanted by newer less toxic immunosuppressants.39
In this regard, NIM811, a nonimmunosuppressive derivative of CsA that inhibits MPT pore
opening,24 may be a more useful cytoprotective agent than CsA. In addition to protecting
against storage/reperfusion injury (Figs. 1-4), NIM811 attenuates myocardial apoptosis and
necrosis when used at reperfusion after acute myocardial ischemia34 and also decreases
reperfusion injury after small-for-size rat liver transplantation.40
The danger of bacterial infection necessitates prophylactic antibiotic use in most
gastrointestinal surgery. To decrease the incidence of posttransplant infection, many centers
supplement parenteral broad-spectrum antibiotics with regimens of oral antimicrobial agents.
41 Antibiotics, including penicillin, streptomycin, and others, are also routinely added to the
University of Wisconsin storage solution.42 Thus, treatment with minocycline of stored livers
and graft recipients could be consistent with current clinical practice and have the additional
benefit of decreasing storage/reperfusion injury. Future studies will be needed to determine
what benefit, if any, minocycline and other MPT inhibitors might have in human clinical liver
transplantation.
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Minocycline and NIM811 decrease ALT release after rat liver transplantation. Serum ALT
was assessed 6 hours after sham operation or rat liver transplantation. Explants and recipients
were treated with vehicle (lactated Ringer's solution), minocycline (18 μM to explants, 10 mg/
kg to recipients), tetracycline (18 μM to explants, 10 mg/kg to recipients), or NIM811 (5 μM
to explants, 10 mg/kg to recipients). Group sizes were: sham, 4; vehicle, 21; minocycline, 10;
tetracycline, 10; NIM811, 8. *P< 0.05.
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Minocycline and NIM811 decrease necrosis after liver transplantation. Rat livers were
transplanted, as described in Fig. 1. At 6 hours postoperatively, necrosis was assessed by
hematoxylin-eosin histology in sham-operated (A), vehicle-treated (B), minocycline-treated
(C), and NIM811-treated (D) grafts. Dashed lines identify necrotic areas. (E) Necrosis as
percent area in liver sections averaged from 5 livers per group. Necrosis in sham was absent
and not plotted. Bar is 100 μm. *P < 0.05 versus vehicle.
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Minocycline and NIM811 decrease apoptosis after rat liver transplantation. Rat livers were
transplanted, as described in Fig. 1. At 6 hours postoperatively, TUNEL was assessed in
sections of sham-operated (A), vehicle-treated (B), minocycline-treated (C), and NIM811-
treated (D) grafts. (E and F) TUNEL in parenchymal (PC) and nonparenchymal (NPC) cells.
TUNEL for sham was virtually zero and not plotted. (G) Caspase 3 activity in liver
homogenates at 6 hours after transplantation as fold increase over sham operation. Bar is 50
μm. *P < 0.05 versus vehicle.
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Minocycline and NIM811 improve survival after liver transplantation. Thirty-day survival was
assessed in rats subjected to liver transplantation after treatments with vehicle, minocycline,
NIM811, or tetracycline, as described in Fig. 1. Size of individual groups was 9 to 11. *P <
0.05 compared with vehicle and tetracycline.
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Minocycline inhibits calcium-induced swelling of isolated mitochondria. Swelling of rat liver
mitochondria was monitored by absorbance, as described in Materials and Methods. CaCl2
(250 μM) was added at arrow except for tracing marked No Ca2+. Two minutes before
CaCl2 addition, mitochondria were treated with minocycline (Mino), tetracycline (Tetra), or 1
μM CsA.
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Minocycline inhibits calcium uptake without altering oxidative phosphorylation or energetic
efficiency of calcium accumulation. Free Ca2+ was measured from Fluo-5N fluorescence, and
oxygen consumption was measured polarographically, as described in Materials and Methods.
(A) Mitochondria were preincubated with dimethylsulfoxide, 5 μM NIM811, or 1 μM CsA.
After 2 minutes, 50 μM CaCl2 was added every 5 minutes (arrows). (B) Mitochondria were
preincubated for 2 minutes with 18 μM minocycline or 18 μM tetracycline, and CaCl2 was
added as in (A). (C) State 4 and state 3 respiration were measured before and after addition of
218 μM ADP or 250 μM CaCl2, as described in Materials and Methods. ADP/O and Ca2+/O
ratios were calculated from total oxygen consumed during state 3 respiration from 3 or more
measurements. *P < 0.05, **P < 0.05 versus no minocycline.
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Minocycline and NIM811 decrease mitochondrial depolarization and cell death after rat liver
transplantation. Donor livers and graft recipients were treated with vehicle, minocycline, or
NIM811, as described in Fig. 1. At 4 hours postoperatively, liver grafts were visualized by
intravital multiphoton microscopy of rhodamine 123 and PI fluorescence. Shown are
representative overlay images of green rhodamine 123 and red PI fluorescence collected from
livers after sham operation (A) and liver grafts after vehicle (B), minocycline (C), and NIM811
(D) treatment. Punctate staining of rhodamine 123 denoted polarization of individual
mitochondria, whereas dim diffuse cellular staining indicated mitochondrial depolarization
(white arrows). PI nuclear staining signified loss of cell viability (yellow arrows). (E)
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Quantification of the time course of mitochondrial depolarization and cell death after liver
transplantation as a percentage of hepatocytes using intravital spinning disk confocal
microscopy performed after sham operation (0 hours) and at 2-6 hours postoperatively.
Individual group sizes were 3-4 rats per time-point. *P < 0.05 versus other group. (F)
Quantification of numbers per HPF of viable parenchymal cells (PC) with depolarized
mitochondria, nonviable PC, and nonviable nonparenchymal cells (NPC) at 4 hours after
transplantation from intravital multiphoton microscopy. Size of individual groups was 5. Bar
is 30 μm. *P < 0.05.
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